Cargando…

Variation in the use of infection control measures and infection-related revision incidence after breast implant surgery in the Netherlands

BACKGROUND: The use and effect of most infection control measures (ICMs) in breast implant surgery are still debated, likely resulting in undesired variation in current practices. OBJECTIVES: This study investigated the relationship between the number and combinations of ICMs used and the infection-...

Descripción completa

Detalles Bibliográficos
Autores principales: Becherer, Babette E., Marang-van de Mheen, Perla J., Young-Afat, Danny A., van der Hulst, Rene R.J.W., Keuter, Xavier H.A., Rakhorst, Hinne A., Mureau, Marc A.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713279/
https://www.ncbi.nlm.nih.gov/pubmed/36466313
http://dx.doi.org/10.1016/j.jpra.2022.10.004
_version_ 1784841983991218176
author Becherer, Babette E.
Marang-van de Mheen, Perla J.
Young-Afat, Danny A.
van der Hulst, Rene R.J.W.
Keuter, Xavier H.A.
Rakhorst, Hinne A.
Mureau, Marc A.M.
author_facet Becherer, Babette E.
Marang-van de Mheen, Perla J.
Young-Afat, Danny A.
van der Hulst, Rene R.J.W.
Keuter, Xavier H.A.
Rakhorst, Hinne A.
Mureau, Marc A.M.
author_sort Becherer, Babette E.
collection PubMed
description BACKGROUND: The use and effect of most infection control measures (ICMs) in breast implant surgery are still debated, likely resulting in undesired variation in current practices. OBJECTIVES: This study investigated the relationship between the number and combinations of ICMs used and the infection-related revision incidence after breast implant surgery. Additionally, national variation between Dutch healthcare institutions in ICM use was evaluated. METHODS: For this multicentre, population-based study, all patients who received a primary breast implant or tissue expander for breast augmentation or reconstruction between 2015 and 2019 were identified from the Dutch Breast Implant Registry. Seven prospectively collected ICMs were investigated: preoperative antibiotics, implant and/or pocket irrigation, glove change, nipple guards, insertion sleeve, postoperative drains, and postoperative antibiotics. RESULTS: This study included 52,415 implants (85% augmentation, 15% reconstruction).The median (IQR) number of ICMs used was 3 (3-4) for augmentation and 4 (4-5) for reconstruction. Median follow-up was 30 months for augmentation and 34 months for reconstruction. Infection-related revision incidence was 0.1% for augmentation and 2.1% for reconstruction. Most infection-related revisions occurred within 2 months for augmentation and 2.5 months for reconstruction. The impact of ICM use on infection-related revision incidence remained unclear, given its low incidence. A significant variation was observed between institutions in the use of postoperative antibiotics and drains. CONCLUSIONS: Although the use of different ICMs varied considerably between institutions, the infection-related revision incidence after breast implant surgery was generally low. Most surgeons used four ICMs for breast reconstruction and three ICMs for breast augmentation. Further studies on the causes and effects of the observed variation are needed.
format Online
Article
Text
id pubmed-9713279
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-97132792022-12-02 Variation in the use of infection control measures and infection-related revision incidence after breast implant surgery in the Netherlands Becherer, Babette E. Marang-van de Mheen, Perla J. Young-Afat, Danny A. van der Hulst, Rene R.J.W. Keuter, Xavier H.A. Rakhorst, Hinne A. Mureau, Marc A.M. JPRAS Open Original Article BACKGROUND: The use and effect of most infection control measures (ICMs) in breast implant surgery are still debated, likely resulting in undesired variation in current practices. OBJECTIVES: This study investigated the relationship between the number and combinations of ICMs used and the infection-related revision incidence after breast implant surgery. Additionally, national variation between Dutch healthcare institutions in ICM use was evaluated. METHODS: For this multicentre, population-based study, all patients who received a primary breast implant or tissue expander for breast augmentation or reconstruction between 2015 and 2019 were identified from the Dutch Breast Implant Registry. Seven prospectively collected ICMs were investigated: preoperative antibiotics, implant and/or pocket irrigation, glove change, nipple guards, insertion sleeve, postoperative drains, and postoperative antibiotics. RESULTS: This study included 52,415 implants (85% augmentation, 15% reconstruction).The median (IQR) number of ICMs used was 3 (3-4) for augmentation and 4 (4-5) for reconstruction. Median follow-up was 30 months for augmentation and 34 months for reconstruction. Infection-related revision incidence was 0.1% for augmentation and 2.1% for reconstruction. Most infection-related revisions occurred within 2 months for augmentation and 2.5 months for reconstruction. The impact of ICM use on infection-related revision incidence remained unclear, given its low incidence. A significant variation was observed between institutions in the use of postoperative antibiotics and drains. CONCLUSIONS: Although the use of different ICMs varied considerably between institutions, the infection-related revision incidence after breast implant surgery was generally low. Most surgeons used four ICMs for breast reconstruction and three ICMs for breast augmentation. Further studies on the causes and effects of the observed variation are needed. Elsevier 2022-10-12 /pmc/articles/PMC9713279/ /pubmed/36466313 http://dx.doi.org/10.1016/j.jpra.2022.10.004 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Article
Becherer, Babette E.
Marang-van de Mheen, Perla J.
Young-Afat, Danny A.
van der Hulst, Rene R.J.W.
Keuter, Xavier H.A.
Rakhorst, Hinne A.
Mureau, Marc A.M.
Variation in the use of infection control measures and infection-related revision incidence after breast implant surgery in the Netherlands
title Variation in the use of infection control measures and infection-related revision incidence after breast implant surgery in the Netherlands
title_full Variation in the use of infection control measures and infection-related revision incidence after breast implant surgery in the Netherlands
title_fullStr Variation in the use of infection control measures and infection-related revision incidence after breast implant surgery in the Netherlands
title_full_unstemmed Variation in the use of infection control measures and infection-related revision incidence after breast implant surgery in the Netherlands
title_short Variation in the use of infection control measures and infection-related revision incidence after breast implant surgery in the Netherlands
title_sort variation in the use of infection control measures and infection-related revision incidence after breast implant surgery in the netherlands
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713279/
https://www.ncbi.nlm.nih.gov/pubmed/36466313
http://dx.doi.org/10.1016/j.jpra.2022.10.004
work_keys_str_mv AT bechererbabettee variationintheuseofinfectioncontrolmeasuresandinfectionrelatedrevisionincidenceafterbreastimplantsurgeryinthenetherlands
AT marangvandemheenperlaj variationintheuseofinfectioncontrolmeasuresandinfectionrelatedrevisionincidenceafterbreastimplantsurgeryinthenetherlands
AT youngafatdannya variationintheuseofinfectioncontrolmeasuresandinfectionrelatedrevisionincidenceafterbreastimplantsurgeryinthenetherlands
AT vanderhulstrenerjw variationintheuseofinfectioncontrolmeasuresandinfectionrelatedrevisionincidenceafterbreastimplantsurgeryinthenetherlands
AT keuterxavierha variationintheuseofinfectioncontrolmeasuresandinfectionrelatedrevisionincidenceafterbreastimplantsurgeryinthenetherlands
AT rakhorsthinnea variationintheuseofinfectioncontrolmeasuresandinfectionrelatedrevisionincidenceafterbreastimplantsurgeryinthenetherlands
AT mureaumarcam variationintheuseofinfectioncontrolmeasuresandinfectionrelatedrevisionincidenceafterbreastimplantsurgeryinthenetherlands
AT variationintheuseofinfectioncontrolmeasuresandinfectionrelatedrevisionincidenceafterbreastimplantsurgeryinthenetherlands